GenoFAB is a biotechnology company specializing in laboratory information management systems (LIMS) and plasmid management services. Founded in March 2019 and headquartered in Fort Collins, Colorado, GenoFAB aims to enhance the efficiency and reproducibility of life science research through automation and standardized processes.
GenoFAB mission is to assist life scientists in translating their ideas into DNA by combining automation, design standards, and transparent documentation. The company operates independently but maintains a close relationship with Colorado State University, providing access to state-of-the-art facilities and a talented team.
Founded by Dr. Jean Peccoud, who holds the Abell Chair in Synthetic Biology at Colorado State University, GenoFAB has developed technologies built on research funded by the National Science Foundation and the NIH. The company's focus is on making genetic design reproducible, scalable, and trustworthy.
GenoFAB is a privately held, venture capital-backed company. As of October 2023, it secured a $100,000 debt financing round. The company has raised a total of $850,000 in funding to date.
GenoFAB offers a suite of services covering the entire plasmid lifecycle:
Plasmid Design: Utilizes advanced algorithms and curated genetic component libraries to create customized plasmids optimized for functionality and regulatory compliance.
Plasmid Synthesis and Assembly: Employs bioinformatics and optimization algorithms to maximize the reuse of existing genetic material, minimizing the need for de novo synthesis.
Biobanking: Implements advanced inventory management technologies, including proprietary LIMS, for precise oversight and efficient sample handling.
Whole Plasmid Sequencing: Introduced a hybrid sequencing service combining Illumina and Oxford Nanopore technologies to enhance reproducibility and quality control in biotechnology research and biomanufacturing.
GenoFAB continues to innovate, with recent developments including:
Hybrid Plasmid Sequencing Service: Enhances plasmid quality control by combining Illumina and Oxford Nanopore sequencing technologies.
GenoFAB emphasizes innovation, reproducibility, and scalability in genetic design. The company values transparency and efficiency, aiming to make genetic design trustworthy and accessible for life scientists.
GenoFAB serves a diverse clientele, including academic scientists, biotech companies, and operators of biomanufacturing facilities. Its services are tailored to meet the needs of various stakeholders in the life sciences, from early-stage research to commercial manufacturing.
GenoFAB
By GenoFAB, Inc
